Central and Peripheral Airway Sites of Nitric Oxide Gas Exchange in COPD

被引:22
|
作者
Gelb, Arthur F. [1 ,3 ]
Taylor, Colleen Flynn
Krishnan, Anita
Fraser, Christine
Shinar, Chris M. [4 ]
Schein, Mark J. [2 ]
Osann, Kathryn [5 ]
机构
[1] Lakewood Reg Med Ctr, Div Pulm, Dept Med, Lakewood, CA USA
[2] Lakewood Reg Med Ctr, Dept Radiol, Lakewood, CA USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Orange Coast Mem Med Ctr, Dept Performance Improvement & Patient Safety, Fountain Valley, CA USA
[5] Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA 92717 USA
关键词
OBSTRUCTIVE PULMONARY-DISEASE; EXHALED AIR; FLOW-RATE; ALVEOLAR; ASTHMA; EXACERBATIONS; INFLAMMATION; HEALTHY; SPUTUM; NO;
D O I
10.1378/chest.09-1522
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: This study investigated sites of nitric oxide (NO) gas exchange and response to inhaled corticosteroids (ICS) in patients with COPD and varying extents of emphysema. Methods: This was a prospective, randomized, single-blind, crossover study in treated, stable, ex-smoking patients with COPD who were ICS and leukotriene receptor antagonists naive. Lung function, high-resolution thin-section CT scan of the lung, and exhaled NO were measured at 50, 100, 150, and 200 mL/s. Airway NO was adjusted for NO axial backdiffusion. Results: In 39 (18 women), clinically stable ex-smokers with COPD aged 73 +/- 9 years (mean +/- SD) on salmeterol 50 mu g (S50) bid, after 180 mu g aerosolized albuterol, FEV1 (L) was 52% +/- 12% predicted and FEV1/FVC was 55% +/- 6%. Compared with 20 (12 men) age-matched controls, 39 patients with COPD had normal large airway NO flux and small airway/alveolar NO. Subsequently, 19 patients with COPD (Group A) were randomized and continued on S50, and 20 (Group B) were randomized to fluticasone propionate 250 mu g (F250)/S50 bid for 86 +/- 16 days. Group A (S50) patients were then switched to F250/S50, and 12 of 19 completed 77 +/- 15 days; there was significant (P < .001) reduction only in the exhaled fraction of NO (FENO) at 50 mL/s and large airway NO flux. In 20 patients with COPD initially randomized to F250/S50 (Group B), after 57 +/- 22 days of S50 in 16 of 20 patients there was a significant (P = .04) increase only in (FENO) at 50 mL/s and large airway NO flux, which was not reduced after 60 +/- 23 days of fluticasone propionate 100 mu g (F100)/S50(P = .07). There was no correlation between NO gas exchange and CT-scored emphysema. Conclusions: In COPD, there was; normal NO gas exchange in both large and small airways/alveoli and only large airway NO flux was suppressed with F250/S50 but not F100/S50, despite varying extents of emphysema. Peripheral NO must be corrected for axial NO backdiffusion to avoid spurious conclusions. CHEST 2010; 137(3):575-584
引用
收藏
页码:575 / 584
页数:10
相关论文
共 50 条
  • [1] Central and peripheral airway/alveolar sites of exhaled nitric oxide in acute asthma
    Gelb, Arthur F.
    George, Steven C.
    Silkoff, Philip E.
    Krishnan, Anita
    Fraser, Christine
    Taylor, Colleen Flynn
    Shinar, Chris M.
    Maginot, Tamara
    THORAX, 2010, 65 (07) : 619 - 625
  • [2] COPD patients with peripheral airway obstruction reversibility identified by exhaled nitric oxide
    Perez-Bogerd, Silvia
    Michils, Alain
    Malinovschi, Andrei
    Van Muylem, Alain
    JOURNAL OF BREATH RESEARCH, 2019, 13 (03)
  • [3] A Novel Approach to Partition Central and Peripheral Airway Nitric Oxide
    Paredi, Paolo
    Kharitonov, Sergei A.
    Meah, Sally
    Barnes, Peter J.
    Usmani, Omar S.
    CHEST, 2014, 145 (01) : 113 - 119
  • [4] Increased Nitric Oxide Concentrations in the Small Airway of Older Normal Subjects
    Gelb, Arthur E.
    George, Steven C.
    Camacho, Fernando
    Fraser, Christine
    Taylor, Colleen Flynn
    Shakkottai, Sreelakshmi
    CHEST, 2011, 139 (02) : 368 - 375
  • [5] Blood Eosinophils and Exhaled Nitric Oxide: Surrogate Biomarkers of Airway Eosinophilia in Stable COPD and Exacerbation
    Antus, Balazs
    Barta, Imre
    BIOMEDICINES, 2022, 10 (09)
  • [6] Predictive Value of Exhaled Nitric Oxide and Blood Eosinophil Count in the Assessment of Airway Eosinophilia in COPD
    Antus, Balazs
    Paska, Csilla
    Barta, Imre
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 2025 - 2035
  • [7] Bronchial and peripheral airway nitric oxide in primary ciliary dyskinesia and bronchiectasis
    Shoemark, A.
    Wilson, R.
    RESPIRATORY MEDICINE, 2009, 103 (05) : 700 - 706
  • [8] Central airway and peripheral lung structures in airway disease-dominant COPD
    Tanabe, Naoya
    Shimizu, Kaoruko
    Terada, Kunihiko
    Sato, Susumu
    Suzuki, Masaru
    Shima, Hiroshi
    Oguma, Akira
    Oguma, Tsuyoshi
    Konno, Satoshi
    Nishimura, Masaharu
    Hirai, Toyohiro
    ERJ OPEN RESEARCH, 2021, 7 (01)
  • [9] Airway and systemic nitric oxide pathway in COPD
    Horvath, Peter
    Csoma, Balazs
    Nagy, Lajos
    Toth, Bence
    Tabi, Tamas
    Szucs, Gergo
    Komlosi, Zsolt Istvan
    Mueller, Veronika
    Losonczy, Gyorgy
    Lazar, Zsofia
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [10] Exhaled Nitric Oxide Predicts Eosinophilic Airway Inflammation in COPD
    Chou, Kun-Ta
    Su, Kang-Cheng
    Huang, Shiang-Fen
    Hsiao, Yi-Han
    Tseng, Ching-Min
    Su, Vincent Yi-Fong
    Hung, Shih-Chieh
    Perng, Diahn-Warng
    LUNG, 2014, 192 (04) : 499 - 504